Ophthalmology

Ask MedXY AI

What is the latest evidence?Key clinical updates Guideline changes

Latest news

Clinical Updatesclinical trialsTeprotumumab

Veligrotug Emerges as a Promising Therapy for Thyroid Eye Disease: Insights from the THRIVE and THRIVE-2 Trials

By MedXY|Sep 30, 2025

Veligrotug demonstrates robust efficacy and manageable safety in both active and chronic thyroid eye disease, positioning itself as a potential alternative to teprotumumab based on phase 3 THRIVE trial data.

Clinical UpdatesGLP-1liraglutide

GLP-1 Receptor Agonists Linked to Early Risk of Optic Nerve Damage: A Case-Control Study Analysis

By MedXY|Sep 30, 2025

GLP-1 receptor agonist use, especially liraglutide, is associated with a higher risk of nonarteritic anterior ischemic optic neuropathy (NAION) during the first year, particularly in patients without diabetes or obesity.

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articles Cardiology1375 articles Clinical Updates1288 articles Oncology1139 articles Diabetes & Endocrinology842 articles Neurology820 articles Public Health595 articles Gastroenterology572 articles